Literature DB >> 17665230

Evaluation and comparison of fluorescence polarization assay with three of the currently used serological tests in diagnosis of human brucellosis.

A Konstantinidis1, A Minas, S Pournaras, A Kansouzidou, P Papastergiou, A Maniatis, N Stathakis, C Hadjichristodoulou.   

Abstract

Fluorescence polarization assay (FPA) is a method that has been used for the diagnosis of brucellosis in animals for many years. To test its possible usefulness for the diagnosis of human brucellosis, 230 sera from patients with clinical signs of brucellosis and positive serological tests (Rose Bengal, Standard Agglutination Test, iELISA), and 305 sera from a healthy population with no clinical/epidemiological/serological evidence were examined with FPA. By using ROC analysis, the cut-off value was estimated at 99 mP, with 93.5% sensitivity (95% CI 89.5-96.3) and 96.1% specificity (95% CI 93.2-97.9). The pairwise comparison of ROC curves between FPA and iELISA and between FPA and RBT revealed no significant statistic difference (P < 0.05). On the contrary it revealed a significant statistic difference between FPA and SAT (P > 0.05). SAT also had the lowest sensitivity (81.7%) among the three tests used in case definition while iELISA had a sensitivity of 90.8% and RBT a sensitivity of 88.7%. The Kappa analysis showed that FPA has a very good agreement (0.92) with the "status of the disease" and with iELISA (0.837). According to our results, FPA seems to be a valuable method for the diagnosis of brucellosis in humans. Taking into consideration the advantages of the method such as the speed of results obtaining, the objectivity of results interpretation, as well as the cost, FPA could be considered as a replacement for other established methods. However, further studies are needed to assess the reproducibility of FPA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665230     DOI: 10.1007/s10096-007-0363-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Surveillance of brucellosis in a rural area of Greece: application of the computerized mapping programme.

Authors:  C Hadjichristodoulou; E Soteriades; G Goutzianna; M Loukaidou; T Babalis; M Antoniou; J Delagramaticas; Y Tselentis
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis.

Authors:  George F Araj; Mireille M Kattar; Layla G Fattouh; Kayane O Bajakian; Sara A Kobeissi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

Review 3.  The new global map of human brucellosis.

Authors:  Georgios Pappas; Photini Papadimitriou; Nikolaos Akritidis; Leonidas Christou; Epameinondas V Tsianos
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

Review 4.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

5.  Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas.

Authors:  J D Ruiz-Mesa; J Sánchez-Gonzalez; J M Reguera; L Martín; S Lopez-Palmero; J D Colmenero
Journal:  Clin Microbiol Infect       Date:  2005-03       Impact factor: 8.067

6.  An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe.

Authors:  V Taleski; L Zerva; T Kantardjiev; Z Cvetnic; M Erski-Biljic; B Nikolovski; J Bosnjakovski; V Katalinic-Jankovic; A Panteliadou; S Stojkoski; T Kirandziski
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

7.  Validation of fluorescence polarization assay (FPA) and comparison with other tests used for diagnosis of B. melitensis infection in sheep.

Authors:  A Minas; A Stournara; M Minas; A Papaioannou; V Krikelis; S Tselepidis
Journal:  Vet Microbiol       Date:  2005-11-08       Impact factor: 3.293

Review 8.  Human brucellosis: a classical infectious disease with persistent diagnostic challenges.

Authors:  G F Araj
Journal:  Clin Lab Sci       Date:  1999 Jul-Aug

9.  Diagnosis of bovine brucellosis using a homogeneous fluorescence polarization assay.

Authors:  K Nielsen; D Gall; M Lin; C Massangill; L Samartino; B Perez; M Coats; S Hennager; A Dajer; P Nicoletti; F Thomas
Journal:  Vet Immunol Immunopathol       Date:  1998-12-11       Impact factor: 2.046

Review 10.  Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature.

Authors:  E J Young
Journal:  Rev Infect Dis       Date:  1991 May-Jun
View more
  5 in total

1.  Bayesian estimation of the seroprevalence of brucellosis in humans and livestock in Kyrgyzstan.

Authors:  S Dürr; B Bonfoh; E Schelling; J Kasymbekov; M G Doherr; N Toktobaev; T Schueth; J Zinsstag
Journal:  Rev Sci Tech       Date:  2013-12       Impact factor: 1.181

2.  The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease.

Authors:  Ramón Díaz; Aurora Casanova; Javier Ariza; Ignacio Moriyón
Journal:  PLoS Negl Trop Dis       Date:  2011-04-19

3.  Latent class evaluation of three serological tests for the diagnosis of human brucellosis in Bangladesh.

Authors:  A K M A Rahman; C Saegerman; D Berkvens
Journal:  Trop Med Health       Date:  2016-10-04

4.  Fluorescence polarization assay improves the rapid detection of human brucellosis in China.

Authors:  Shuai-Bing Dong; Di Xiao; Jing-Yao Liu; Hui-Mei Bi; Zun-Rong Zheng; Li-Da Wang; Xiao-Wen Yang; Guo-Zhong Tian; Hong-Yan Zhao; Dong-Ri Piao; Zhi-Feng Xing; Hai Jiang
Journal:  Infect Dis Poverty       Date:  2021-03-31       Impact factor: 4.520

5.  Performance characteristics and costs of serological tests for brucellosis in a pastoralist community of northern Tanzania.

Authors:  AbdulHamid S Lukambagire; Ângelo J Mendes; Rebecca F Bodenham; John A McGiven; Nestory A Mkenda; Coletha Mathew; Matthew P Rubach; Philoteus Sakasaka; Davis D Shayo; Venance P Maro; Gabriel M Shirima; Kate M Thomas; Christopher J Kasanga; Rudovick R Kazwala; Jo E B Halliday; Blandina T Mmbaga
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.